BYFAVO is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Acacia Pharma Ltd. The primary component is Remimazolam Besylate.
Product ID | 71390-011_4c6a7829-111f-496f-94a9-870568876c2b |
NDC | 71390-011 |
Product Type | Human Prescription Drug |
Proprietary Name | BYFAVO |
Generic Name | Remimazolam Besylate |
Dosage Form | Injection, Powder, Lyophilized, For Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2020-07-02 |
Marketing Category | NDA / NDA |
Application Number | NDA212295 |
Labeler Name | Acacia Pharma Ltd |
Substance Name | REMIMAZOLAM BESYLATE |
Active Ingredient Strength | 3 mg/mL |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2020-10-06 |
NDC Exclude Flag | N |
Sample Package? | N |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
BYFAVO 88817162 not registered Live/Pending |
Cosmo Technologies Ltd 2020-03-02 |
BYFAVO 88099395 not registered Live/Pending |
Cosmo Technologies Ltd 2018-08-30 |